Blog

Speaking of Risk: Pharmaceutical Companies and Third Party Promotions

Pharmaceutical companies around the world are struggling to keep up with the rapid evolution of ethical frameworks around bribery and corruption in their industry.
Read More

Topics: Pharma, Anti-bribery & Anti-corruption, FCPA, Medical Companies, SEC, Corruption, Bribery, DOJ, teva, Pharmaceutical Companies, settlement, fines, gsk

FCPA Third-Party Risk and Compliance for Pharmaceutical Companies

Around the world, governments are getting stricter about enforcing anti-bribery and anti-corruption regulations such as the U.S. Foreign Corrupt Practices Act (FCPA), the U.K. Anti-Bribery Act, and other national laws modelled on the OECD Anti-Bribery Convention. These regulations forbid bribery and corruption by companies and their third-party partners, including resellers, distributors, and marketing agencies.

Read More

Topics: Pharma, FCPA, Anti-Bribery and Anti-Corruption